These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 851711)

  • 1. Dangerous reactions to treatment of onchocerciasis with diethylcarbamazine.
    Bryceson AD; Warrell DA; Pope HM
    Br Med J; 1977 Mar; 1(6063):742-4. PubMed ID: 851711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Mazzotti reaction following treatment of onchocerciasis with diethylcarbamazine: clinical severity as a function of infection intensity.
    Francis H; Awadzi K; Ottesen EA
    Am J Trop Med Hyg; 1985 May; 34(3):529-36. PubMed ID: 4003668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eosinophil degranulation. An immunologic determinant in the pathogenesis of the Mazzotti reaction in human onchocerciasis.
    Ackerman SJ; Kephart GM; Francis H; Awadzi K; Gleich GJ; Ottesen EA
    J Immunol; 1990 May; 144(10):3961-9. PubMed ID: 2332637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Description, mechanisms and control of reactions to treatment in the human filariases.
    Ottesen EA
    Ciba Found Symp; 1987; 127():265-83. PubMed ID: 3297558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microfilariae in the cerebrospinal fluid, and neurological complications, during treatment of onchocerciasis with diethylcarbamazine.
    Duke BO; Vincelette J; Moore PJ
    Tropenmed Parasitol; 1976 Jun; 27(2):123-32. PubMed ID: 941247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy of onchocerciasis with high doses of diethylcarbamazine or a single dose of ivermectin: microfilaria levels and side effects.
    Albiez EJ; Newland HS; White AT; Kaiser A; Greene BM; Taylor HR; Büttner DW
    Trop Med Parasitol; 1988 Mar; 39(1):19-24. PubMed ID: 3291074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in visual function and in the posterior segment of the eye during treatment of onchocerciasis with diethylcarbamazine citrate.
    Bird AC; el-Sheikh H; Anderson J; Fuglsang H
    Br J Ophthalmol; 1980 Mar; 64(3):191-200. PubMed ID: 7387952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in natural killer cell activity during diethylcarbamazine treatment of patients with filariasis.
    Pedersen BK; Bygbjerg IC; Svenson M
    Acta Trop; 1987 Sep; 44(3):353-5. PubMed ID: 2892372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and laboratory changes consequent to diethylcarbamazine in patients with onchocerciasis.
    Fazen LE; Anderson RI; Fazen LE; Marroquin HF
    Am J Trop Med Hyg; 1976 Mar; 25(2):250-6. PubMed ID: 1259086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deposition of eosinophil granule major basic protein onto microfilariae of Onchocerca volvulus in the skin of patients treated with diethylcarbamazine.
    Kephart GM; Gleich GJ; Connor DH; Gibson DW; Ackerman SJ
    Lab Invest; 1984 Jan; 50(1):51-61. PubMed ID: 6363816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The chemotherapy of onchocerciasis VII. The effect of prednisone on the Mazzotti reaction.
    Awadzi K; Orme ML; Breckenridge AM; Gilles HM
    Ann Trop Med Parasitol; 1982 Jun; 76(3):331-8. PubMed ID: 6751250
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.
    Greene BM; Taylor HR; Cupp EW; Murphy RP; White AT; Aziz MA; Schulz-Key H; D'Anna SA; Newland HS; Goldschmidt LP
    N Engl J Med; 1985 Jul; 313(3):133-8. PubMed ID: 3892293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Letter: Collapse during treatment of onchocerciasis with diethylcarbamazine.
    Fuglsang H; Anderson J
    Trans R Soc Trop Med Hyg; 1974; 68(1):72-3. PubMed ID: 4818668
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of flubendazole and diethylcarbamazine in treatment of onchocerciasis.
    Dominguez-Vazquez A; Taylor HR; Greene BM; Ruvalcaba-Macias AM; Rivas-Alcala AR; Murphy RP; Beltran-Hernandez F
    Lancet; 1983 Jan; 1(8317):139-43. PubMed ID: 6130195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy of onchocerciasis: a controlled comparison of mebendazole, levamisole, and diethylcarbamazine.
    Rivas-Alcalá AR; Greene BM; Taylor HR; Domíguez-Vázquez A; Ruvalcaba-Macías AM; Lugo-Pfeiffer C; Mackenzie CD; Beltrán F
    Lancet; 1981 Sep; 2(8245):485-90. PubMed ID: 6115246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular and systemic complications of diethylcarbamazine therapy for onchocerciasis: association with circulating immune complexes.
    Greene BM; Taylor HR; Brown EJ; Humphrey RL; Lawley TJ
    J Infect Dis; 1983 May; 147(5):890-7. PubMed ID: 6842023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular immunopathologic findings of experimental onchocerciasis.
    Donnelly JJ; Rockey JH; Bianco AE; Soulsby EJ
    Arch Ophthalmol; 1984 Apr; 102(4):628-34. PubMed ID: 6704026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further studies on the treatment of ocular onchocerciasis with diethylcarbamazine and suramin.
    Anderson J; Fuglsang H
    Br J Ophthalmol; 1978 Jul; 62(7):450-7. PubMed ID: 678497
    [No Abstract]   [Full Text] [Related]  

  • 19. [Onchocerciasis chemotherapy (author's transl)].
    Prod'hon J; Moreau JP; Mongin C
    Med Trop (Mars); 1979; 39(6):619-28. PubMed ID: 530048
    [No Abstract]   [Full Text] [Related]  

  • 20. Bacterial endosymbionts of Onchocerca volvulus in the pathogenesis of posttreatment reactions.
    Keiser PB; Reynolds SM; Awadzi K; Ottesen EA; Taylor MJ; Nutman TB
    J Infect Dis; 2002 Mar; 185(6):805-11. PubMed ID: 11920298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.